(2026). Cabergoline monotherapy in GH- and PRL-cosecreting pituitary adenomas. Endocrine Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Cabergoline Monotherapy in GH- and PRL-cosecreting Pituitary Adenomas."
Endocrine Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Cabergoline Monotherapy in GH- and PRL-cosecreting Pituitary Adenomas."
Endocrine Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.